Home / News / CMS advises on the disposal of IBL to Tecan

CMS advises on the disposal of IBL to Tecan

12/08/2014

Tecan Group AG, the listed Swiss provider of laboratory technology, acquires IBL International Holding BV, a developer and manufacturer of immunoassays, for an amount of EUR 29 million.

The team of CMS Amsterdam advising IBL consisted of Reinout Slot, Christian Delgado, Marlene Veenman, Abbas Ali Hyder, Gordon Tichelaar and Martijn van der Bie. A team of CMS Hamburg consisting of Hilke Herchen, Nils Maack, Ronald Brettner, Joern Witt, Roland Wiring, Hermann Mueller and Oliver Freitag also advised on the deal.

Related people

Portrait of Reinout Slot
Reinout Slot
Partner
Amsterdam
Portrait of Martijn Bie
Martijn van der Bie
Partner
Amsterdam
Portrait of Christian Delgado
Christian Delgado
Marlene Veenman
Abbas Ali Hyder
Show more Show less